Mayflower Financial Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$297K Sell
565
-5
-0.9% -$2.8K 0.03% 381
2026
Q1
$320K Buy
570
+35
+7% +$22.4K 0.04% 338
2025
Q4
$362K Buy
535
+4
+0.8% +$2.72K 0.04% 301
2025
Q3
$339K Buy
531
+2
+0.4% +$1.21K 0.04% 318
2025
Q2
$284K Sell
529
-4
-0.8% -$1.91K 0.04% 323
2025
Q1
$224K Buy
533
+19
+4% +$8.25K 0.03% 360
2024
Q4
$213K Buy
514
+17
+3% +$7.46K 0.03% 363
2024
Q3
$251K Sell
497
-4
-0.8% -$1.94K 0.04% 320
2024
Q2
$244K Buy
501
+4
+0.8% +$2.01K 0.04% 310
2024
Q1
$268K Buy
497
+10
+2% +$5.46K 0.04% 292
2023
Q4
$270K Sell
487
-3
-0.6% -$1.41K 0.04% 282
2023
Q3
$214K Buy
490
+10
+2% +$4.99K 0.03% 309
2023
Q2
$241K Sell
480
-4
-0.8% -$1.92K 0.03% 308
2023
Q1
$242K Buy
+484
New +$232K 0.03% 300
2022
Q2
Sell
-493
Closed -$270K 346
2022
Q1
$270K Buy
493
+18
+4% +$9.47K 0.04% 292
2021
Q4
$313K Sell
475
-2
-0.4% -$1.26K 0.04% 260
2021
Q3
$306K Buy
477
+2
+0.4% +$1.34K 0.04% 258
2021
Q2
$300K Buy
475
+6
+1% +$3.31K 0.04% 244
2021
Q1
$229K Sell
469
-71
-13% -$35.6K 0.03% 265
2020
Q4
$270K Buy
+540
New +$242K 0.05% 220

Other funds holding IDXX

Mayflower Financial Advisors's IDXX Position: Q2 2026 in Review

Mayflower Financial Advisors reduced its Idexx Laboratories (IDXX) stake by 0.88% in Q2 2026, selling an estimated $2.8K and leaving 565 shares worth $297K. The position accounts for 0.03% of the portfolio, ranked #381.

Mayflower Financial Advisors first reported a position in IDXX in Q4 2020 and has held it in 20 quarters since. The position peaked at $362K in Q4 2025. 612 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Mayflower Financial Advisors held 565 shares of Idexx Laboratories worth $297K as of Q2 2026.
  • Mayflower Financial Advisors sold 5 Idexx Laboratories shares in Q2 2026, an estimated $2.8K.
  • Idexx Laboratories made up 0.03% of Mayflower Financial Advisors's portfolio in Q2 2026, its #381 holding.
  • Mayflower Financial Advisors first reported a position in Idexx Laboratories in Q4 2020 and has held it in 20 quarters since.
  • Mayflower Financial Advisors's Idexx Laboratories position peaked at $362K in Q4 2025.
  • 612 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Mayflower Financial Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.